| Application no. and date | 16778600.3 (espacenet) (Federated) (European Patent Register), 20160925 | | Patent/reg. no. and date | DK/EP 3352780, 20231227 | | Publication date | 20180801 | | Priority no. and date | US 201562233032 P, 20150925, US 201615136650, 20160422 | | EP pub. no. and date |
EP 3352780 20180801 | | Effective date | | | Applicant/owner | Xeris Pharmaceuticals, Inc., 1375 West Fulton Street, Suite 1300
Chicago, IL 60607, US | | Applicant ref. no. | 166461 | | Inventor | PRESTRELSKI, Steven, c/o Xeris Pharmaceuticals, Inc.
3208 Red River Street
Suite 300
Austin, TX 78705, US,
DONOVAN, Martin, c/o Xeris Pharmaceuticals, Inc.
3208 Red River Street
Suite 300
Austin, TX 78705, US,
SANDOVAL, Michael, c/o Xeris Pharmaceuticals, Inc.
3208 Red River Street
Suite 300
Austin, TX 78705, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/26 (2006.01) , A61K 47/00 (2006.01) , A61K 47/20 (2006.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61M 5/142 (2006.01) | | Title | Fremgangsmåder til fremstilling af stabile, terapeutiske glucagonformuleringer i aprotiske, polære opløsningsmidler | | Int. application no. | US2016053628 | | Int. publication no. | WO2017053922 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
